Get started
Author

Chiara Maccari

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
2021 · Paola Guglielmelli, Giuseppe G. Loscocco, et al. · Blood Cancer Journal · 116
PDF
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
2021 · Paola Guglielmelli, Arianna Ghirardi, et al. · Blood Advances · 66
PDF
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience
2024 · Giuseppe G. Loscocco, Francesca Gesullo, et al. · Blood Cancer Journal · 47
PDF
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients
2021 · Giuseppe G. Loscocco, Paola Guglielmelli, et al. · American Journal of Hematology · 42
PDF
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
2024 · Paola Guglielmelli, Barbara Mora, et al. · American Journal of Hematology · 39
PDF
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
2022 · Paola Guglielmelli, Giacomo Coltro, et al. · Blood Advances · 37
PDF
The prognostic contribution of CBL , NRAS , KRAS , RUNX1 , and TP53 mutations to mutation‐enhanced international prognostic score systems ( MIPSS70 /plus/plus v2.0) for primary myelofibrosis
2023 · Giuseppe G. Loscocco, Giada Rotunno, et al. · American Journal of Hematology · 36
PDF
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
2022 · Giacomo Coltro, Francesco Mannelli, et al. · Blood Cancer Journal · 28
PDF
Validation of a Bioanalytical Method for the Determination of Synthetic and Natural Cannabinoids (New Psychoactive Substances) in Oral Fluid Samples by Means of HPLC-MS/MS
2020 · Luca Calò, Luca Anzillotti, et al. · Frontiers in Chemistry · 21
PDF
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis
2023 · Paola Guglielmelli, Chiara Maccari, et al. · Blood Cancer Journal · 20
PDF
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis
2021 · Sebastian Fantini, Sebastiano Rontauroli, et al. · Cancers · 19
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
2023 · Laura Calabresi, Chiara Carretta, et al. · American Journal of Hematology · 17
PDF
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis
2022 · Francesco Mannelli, Sara Bencini, et al. · American Journal of Hematology · 17
PDF
CALR mutation burden in essential thrombocythemia and disease outcome
2024 · Paola Guglielmelli, Natasha Szuber, et al. · Blood · 15
PDF
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates
2022 · Giuseppe G. Loscocco, Paola Guglielmelli, et al. · American Journal of Hematology · 14
PDF
DNA methylation is enhanced during Cd hyperaccumulation in Noccaea caerulescens ecotype Ganges
2022 · Serena Galati, Giovanni DalCorso, et al. · Environmental Science and Pollution Research · 13
PDF
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia
2023 · Francesco Mannelli, Matteo Piccini, et al. · Haematologica · 6
PDF
Nitric oxide products and aldehydes in exhaled breath condensate in children with asthma
2021 · Sara Riscassi, Massimo Corradi, et al. · Clinical & Experimental Allergy · 6
A Myelodepletive Phenotype Is Associated with Distinctive Molecular Features and Adverse Outcomes in Patients with Myelofibrosis
2021 · Giacomo Coltro, Francesco Mannelli, et al. · Blood · 6
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
2024 · Giacomo Coltro, Giulio Capecchi, et al. · Haematologica · 5
PDF
A JAK2V617F Variant Allele Frequency Greater Than 50% Identifies Patients with Polycythemia Vera at High Risk for Venous Thrombosis
2021 · Giuseppe Gaetano Loscocco, Paola Guglielmelli, et al. · Blood · 4
A metabolic trade-off between malignant plasma cells and mesenchymal stromal cells sustains multiple myeloma growth
2026 · Giuseppe Taurino, Erika Griffini, et al. · Blood Neoplasia · 2
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML
2025 · Francesco Mannelli, Matteo Piccini, et al. · Blood Cancer Journal · 2
Calr Variant Allele Frequency in Essential Thrombocythemia: Molecular Associations and Impact on Disease Phenotype and Outcome
2023 · Paola Guglielmelli, Natasha Szuber, et al. · Blood · 2
APL-like Subset within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating with Early-Onset Vascular Complications
2023 · Francesca Crupi, Gaia Ciolli, et al. · Blood · 2
PDF
Works count: 47
Citation count: 586
H-index: 14
I10-index: 16
Year
Topic
Type